AIDX News
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2026-08-19 | Current report | SEC filing | 20/20 Biolabs, Inc. filed Form 8-K | 20/20 Biolabs, Inc. filed Form 8-K covering items 5.07. |
| 2026-08-17 | Current report | SEC filing | 20/20 Biolabs, Inc. filed Form 8-K | 20/20 Biolabs, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-08-05 | Current report | SEC filing | 20/20 Biolabs, Inc. filed Form 8-K | 20/20 Biolabs, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2026-07-22 | Current report | SEC filing | 20/20 Biolabs, Inc. filed Form 8-K | 20/20 Biolabs, Inc. filed Form 8-K covering items 1.01,3.01,9.01. |
| 2026-07-01 | Current report | SEC filing | 20/20 Biolabs, Inc. filed Form 8-K | 20/20 Biolabs, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2026-05-26 | Current report | SEC filing | 20/20 Biolabs, Inc. filed Form 8-K | 20/20 Biolabs, Inc. filed Form 8-K covering items 3.03,5.03,9.01. |
| 2026-05-20 | Current report | SEC filing | 20/20 Biolabs, Inc. filed Form 8-K | 20/20 Biolabs, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-04-28 | Current report | SEC filing | 20/20 Biolabs, Inc. filed Form 8-K | 20/20 Biolabs, Inc. filed Form 8-K covering items 1.01,9.01. |
| 2026-04-01 | Current report | SEC filing | 20/20 Biolabs, Inc. filed Form 8-K | 20/20 Biolabs, Inc. filed Form 8-K covering items 2.02,9.01. |